Hem › Atopisk dermatit (eksem) › South Carolina
Kliniska studier för Atopisk dermatit (eksem) i South Carolina
10 studier för Atopisk dermatit (eksem) söker deltagare vid platser i South Carolina.
Städer i South Carolina
Officiell studietext (engelska)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Advanced Dermatology and Cosmetic Surgery - Spartanburg- Site Number : 8400004, Spartanburg
RekryterarObservationsstudie
Ålder 12 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT07290803First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- National Allergy and Asthma Research, LLC, North Charleston
RekryterarFas 1Friska volontärer välkomna
Ålder 18 till 65 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07527923A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Medical University of South Carolina - South Carolina Translational Research Nexus Clinic, Charleston
- Tribe Clinical Research, LLC, Greenville
RekryterarFas 3
Ålder 2 till 11 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06807281A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Charleston
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT07003425A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 12, Anderson
RekryterarFas 2
Ålder 18 till 74 · Alla kön · Uppdaterad 12 aug. 2026 · NCT07037901A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Medical University of South Carolina /ID# 265113, Charleston
RekryterarFas 3
Ålder 2 till 11 · Alla kön · Uppdaterad 6 aug. 2026 · NCT06461897A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Charleston
RekryterarFas 3
6 Months – 11 Years · Alla kön · Uppdaterad 7 juli 2026 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Medical University of South Carolina /ID# 263655, Charleston
- Advanced Dermatology And Cosmetic Surgery - Spartanburg /ID# 267185, Spartanburg
RekryterarFas 3
Ålder 18 till 63 · Alla kön · Uppdaterad 6 juli 2026 · NCT06389136A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- National Allergy and Asthma, North Charleston
- Spartanburg Medical Research, Spartanburg
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 4 maj 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7106, Bluffton
RekryterarObservationsstudie
Ålder 12 och äldre · Alla kön · Uppdaterad 13 mars 2026 · NCT06988605Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.